Attached files
| file | filename |
|---|---|
| 10-Q - FORM 10-Q - KING PHARMACEUTICALS INC | g20793e10vq.htm |
| EX-32.2 - EX-32.2 - KING PHARMACEUTICALS INC | g20793exv32w2.htm |
| EX-31.1 - EX-31.1 - KING PHARMACEUTICALS INC | g20793exv31w1.htm |
| EX-31.2 - EX-31.2 - KING PHARMACEUTICALS INC | g20793exv31w2.htm |
EXHIBIT 32.1
CERTIFICATION
OF CHIEF EXECUTIVE OFFICER
PURSUANT TO SECTION 906 OF THE
SARBANES-OXLEY ACT OF 2002
PURSUANT TO SECTION 906 OF THE
SARBANES-OXLEY ACT OF 2002
In connection with this quarterly report on
Form 10-Q
of King Pharmaceuticals, Inc., I, Brian A. Markison, Chief
Executive Officer of King Pharmaceuticals, Inc., certify,
pursuant to Section 906 of the Sarbanes-Oxley Act of 2002,
that:
1. The report fully complies with the requirements of
Section 13(a) or 15(d) of the Securities Exchange Act of
1934; and
2. The information contained in this report fairly
presents, in all material respects, the financial condition and
results of operations of King Pharmaceuticals, Inc.
/s/ BRIAN
A. MARKISON
Brian A. Markison
President and Chief Executive Officer
Date: November 5, 2009